Zev Wainberg, MD, MSc

Zev Wainberg, MD, MSc, is a Professor of Medicine in the Division of Hematology and Oncology at the University of California, Los Angeles (UCLA). He is also the Co-Director of the Gastrointestinal Oncology Program at UCLA and the Santa Monica Cancer Center. Dr. Wainberg’s clinical interests include the development and testing of new targeted therapies for the treatment of colon cancer, gastric cancer and esophageal cancer.

Articles by Zev Wainberg, MD, MSc

Zev Wainberg, MD, MScGastric Cancer | December 7, 2024
Dr. Wainberg reviews the data on GI malignancies and notes that it is unclear who should receive radiation before surgery.
View More
Zev Wainberg, MD, MScASCO 2024: Focus on GI Oncology | May 28, 2024
Drs. Wainberg and Uboha highlight exciting developments set to occur at the ASCO Meeting, including ESOPEC and ARC-9.
Zev Wainberg, MD, MScGastric Cancer | May 22, 2024
Drs. Wainberg and Uboha discuss updated results from the FIGHT trial, noting improved OS in gastric cancer/GEJ cancer.
Zev Wainberg, MD, MScPancreatic Cancer | May 1, 2024
Dr. Wainberg provides insight on the NAPOLI-3 study that compared NALIRIFOX against nab-paclitaxel plus gemcitabine.